Pulmocide Is A Biopharmaceutical Company Focused On Developing Innovative Inhaled Medicines For Challenging Respiratory Diseasesparticularly Respiratory Fungal Infectionsfounded In 2013The Company Has A Leadership Team With Extensive Experience In Creating Inhaled Therapies For Respiratory And Infectious Diseasespulmocide Is Headquartered In London And Operates As A Private Limited Company The Company S Lead Compoundopelconazoleis An Investigational Inhaled Antifungal Agent Aimed At Treating Pulmonary Aspergillosisa Serious Fungal Lung Diseasecurrently In Phase 3 Clinical Trialsopelconazole Is Designed For Patients With Invasive Pulmonary Aspergillosis Who Have Not Responded Well To Standard Antifungal Treatmentsthe Compound Has Received Several Fda Designationsincluding Orphan Drug Designation And Fast Track Designationwhich May Help Accelerate Its Development And Review Process
No conferences found for this company.
| Company Name | Pulmocide Ltd |
| Country |
United Kingdom
|
| Address | 44 Southampton Buildings London Wc2A 1Ap |
| Telephone | Login to View |
| Login to View |
